VICTORIA, July 13 /PRNewswire-FirstCall/ -- Aspreva Pharmaceuticals Corporation (NASDAQ: ASPV; TSX: ASV), a pharmaceutical company focused on increasing the pool of evidence-based medicines available for patients living with less common diseases, announced today that the company will release financial and business results for the second quarter ending June 30, 2007 on Wednesday, August 1st.
The Company will hold a conference call and webcast beginning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss these results.
Dial-in information: North America (toll free): 1-866-202-4367 International: 1-617-213-8845 Enter passcode: 69947258
The call will be available for replay until Wednesday, August 8th, by calling 1-888-286-8010 (North America) or 1-617-801-6888 (International) and entering the pass code 40996362.
A live webcast will also be available to all interested parties on Aspreva's website: http://www.aspreva.com/. Please click on the "Webcasts and Events" link under the Investors section. A replay of the webcast will be available until the Company's third quarter 2007 conference call.
About Aspreva Pharmaceuticals
Aspreva is a global pharmaceutical company focused on identifying, developing, and, upon approval, commercializing evidence-based medicines for patients living with less common diseases. Aspreva common stock is traded on the NASDAQ Global Select Market under the trading symbol "ASPV" and on the Toronto Stock Exchange under the trading symbol "ASV". Learn more at http://www.aspreva.com/.
CONTACT: Sage Baker, VP, Investor Relations & Corporate Communications, Aspreva Pharmaceuticals, (250) 744-2488 ext. 84270,
